Catherine Blizzard
7PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 07, 2026
Modeling amyotrophic lateral sclerosis (ALS) <i>in vitro</i>: from mechanistic studies to translatable drug discovery.Kathryn G Maskell, Anthony L Cook, Anna E King
|Feb 26, 2024
How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?G Lorenzo Odierna, Steve Vucic, Marcus Dyer
|Aug 30, 2023
Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.Rosemary M Clark, Courtney M Clark, Katherine E A Lewis
|Aug 14, 2021
Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis.Amanda L Wright, Paul A Della Gatta, Sheng Le
|Jul 02, 2021
Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons.Marcus S Dyer, Adele Woodhouse, Catherine A Blizzard
|Oct 16, 2020
Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.Marcus S Dyer, Laura A Reale, Katherine E Lewis
Pageof 2
Frequent Collaborators
4 joint publications
Tracey C Dickson
1 joint publications
Amanda L Wright
1 joint publications
Paul A Della Gatta
1 joint publications
Rebecca San Gil
1 joint publications
Marco Morsch
1 joint publications
Adam K Walker
1 joint publications
Rosemary M Clark
1 joint publications
Courtney M Clark
1 joint publications
Katherine E A Lewis
1 joint publications
Marcus S Dyer
